Search Results 141-150 of 20545 for Ulcerative+colitis

  1. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

    A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis · Overview · Participation ...

  2. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population - Mayo Clinic

    ... Ulcerative Colitis (UC) within the Pediatric Population. Print details. Share ... ulcerative colitis (UC) within the ICN network. This will be a ...

  3. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

    A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.

  4. Hyperbaric oxygen therapy - Doctors & Departments - Mayo Clinic

    Research. Mayo Clinic researchers are examining the use of hyperbaric oxygen therapy in the treatment of moderate to severe ulcerative colitis flares. Mayo's ...

  5. A Study to Assess the Effectiveness and Safety of Risankizumab in Subjects with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate safety and efficacy of risankizumab in subjects with ulcerative colitis (UC) in subjects who responded to induction ...

  6. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

    Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) · More about research at Mayo ...

  7. A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) - Mayo Clinic

    A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) · More about research at Mayo Clinic · Mayo ...

  8. A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Ulcerative Colitis - Mayo Clinic

    The global primary objectives of this study are, in pediatric participants with moderately to severely active ulcerative colitis (UC):. To evaluate the efficacy ...

  9. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis. Print details. Share ...

  10. Proctitis - Diagnosis & treatment - Mayo Clinic

    Proctitis caused by inflammatory bowel disease. Treatment of proctitis related to ulcerative colitis or Crohn's disease focuses on reducing inflammation in the ...